CrushSCI.com
119.0Average days
113Median days
4Fastest days
251Longest days
2902025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

251 days

Cytotoxic activity of selinexor in BRAF V600E -driven pediatric low-grade glioma 3D cultures

Authors
Constantia Zeiser; Marta Emperador; Sonja Herter; Lisa Sigaud; Alexandra Stroh-Dege; Anna Loboda; Anna Kolodziejczak; Simon Zeuner; Lea Joy Digel; Karen Frese; Bruno Chilian; Micaela Freitas; Jens M. Kelm; Ingrid Ǿra; Daniel Vogl; Martin Ulrich Schuhmann; Heike Peterziel; Romain Sigaud; Florian Selt; Till Milde; Olaf Witt; Ina OehmeShow moreShow less
Affiliations
1. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; 2. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; 3. National Center for Tumor Diseases (NCT), NCT Heidelberg, Heidelberg University Hospital, Heidelberg, Germany; 4. Faculty of Medicine, Heidelberg University, Heidelberg, Germany; 5. Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; 6. Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany; 7. Department of Medicine III, Heidelberg University, German Centre for Cardiovascular Research (DZHK), Heidelberg, Germany; 8. TRI Thinking Research Instruments GmbH, Hamburg, Germany; 9. Precomb Therapeutics AG, Hombrechtikon, Switzerland; 10. Lund University, Lund, Sweden; 11. Karolinska University Hospital, Stockholm, Sweden; 12. Department of Neurosurgery, Section of Pediatric Neurosurgery, University Hospital Tuebingen, Tuebingen, Germany; 13. Department of Neurosurgery, Centre of Neurofibromatosis and Schwannomatosis, Centre for Rare Diseases, Division of Pediatric Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 14. Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena and Comprehensive Cancer Center Central Germany (CCCG), Jena, GermanyShow moreShow less
Source PDF DOI Publisher page
79 days

Vascular profiling of the spinal cord and cortex reveals region-specific endothelial dysfunction and fibroblast remodeling in human ALS

Authors
Kuo Liao; Jianing Lin; Yangfan Zhou; Sebastian A. LewandowskiShow moreShow less
Affiliations
1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 2. Center for Molecular Medicine, Karolinska University Hospital, Stockholm, SwedenShow moreShow less
Source PDF DOI Publisher page
116 days

Altered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy

Authors
Constanza Bravo-Rossainz Baez; Xian Xin; Hang Lyu; Daniil Kirianov; Ying Sun; Erik Späte; Mariapia Grassia; Birgit Engeland; Malte Stockebrand; Konstantin Khodosevich; Ulrike B. S. Hedrich; Dirk Isbrandt; Friederike PfeifferShow moreShow less
Affiliations
1. Department of Neurophysiology, Institute of Physiology, University of Tübingen, Tübingen, Germany; 2. Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 3. Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tübingen, Germany; 4. Deutsches Zentrum Für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; 5. Institute for Molecular and Behavioral Neuroscience and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany; 6. Werner Reichardt Centre for Integrative Neuroscience, University of Tübingen, Tübingen, GermanyShow moreShow less
Source PDF DOI Publisher page
129 days

The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas

Authors
Hanna Gött; Jonas Tellermann; Hannes Becker; Christina Fodi; Peter Paßlack; Elgin Hoffmann; Maria Elisa Di Francesco; Daniel J. Merk; Jürgen Honegger; Ghazaleh Tabatabai; Marcos Tatagiba; Felix Behling; Jens SchittenhelmShow moreShow less
Affiliations
1. Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 2. Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 3. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 4. Cluster of Excellence (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, Eberhard-Karls University Tübingen, Tübingen, Germany; 5. Department of Anesthesiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 6. Department of Radiation Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 7. Department of Ophthalmology, Inselspital Bern, University of Bern, Bern, Switzerland; 8. German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany; 9. Department of Neurosurgery, Faculty of Medicine, Augsburg University, Augsburg, Germany; 10. Translational Oncological Neurosurgery, Faculty of Medicine, University Augsburg, Augsburg, Germany; 11. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, GermanyShow moreShow less
Source PDF DOI Publisher page
113 days

A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases

Authors
Leonie Sowoidnich; Aaron L. Norman; Florian Gerstner; Josiane K. Siemund; Jannik M. Buettner; John G. Pagiazitis; Vanessa Dreilich; Konstantin Pilz; Dajun Tian; Charlotte J. Sumner; Angela Paradis; George Z. Mentis; Christian M. SimonShow moreShow less
Affiliations
1. Carl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany; 2. Center for Motor Neuron Biology and Disease, Columbia University, New York, USA; 3. Depts. of Pathology and Cell Biology and Neurology, Columbia University, New York, USA; 4. Biogen, Cambridge, USA; 5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 6. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA; 7. Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, USAShow moreShow less
Source PDF DOI Publisher page
71 days

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation

Authors
Lazaros Lazaridis; Xiaomei Zhou; Raphael Bodensohn; Malte Mohme; Julia Onken; Regina von Manitius; Naomi Houedjissin; Tobias Blau; Ilinca Popp; Sarina Agkatsev; Sabine Seidel; Christina Schaub; Maximilian Scheer; Andre Sagerer; Volker Neuschmelting; Davide Tosin; Viktoria Ruf; Michael C. Burger; Christoph Oster; Teresa Schmidt; Benjamin Thiele; Jürgen Hench; Stephan Frank; Martin Stuschke; Laurèl Rauschenbach; Stephan Tippelt; Beate Timmermann; Kathy Keyvani; Clemens Seidel; Andrea Tannapfel; Dorothea Miller; Niklas Thon; Joachim P. Steinbach; Elke Pfaff; Georg Karpel-Massler; Jörg Felsberg; Guido Reifenberger; Marcos Tatagiba; Ghazaleh Tabatabai; Jens Schittenhelm; Christian Thomas; Martin Hasselblatt; Corinna Seliger; Christoph Kleinschnitz; Ulrich Sure; David Capper; Michael Platten; Felix Behling; Michael Müther; Sied KebirShow moreShow less
Affiliations
1. Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 2. Division of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 3. Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany; 4. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany; 6. Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; 7. Department of Neurosurgery, Medical Faculty, Center of Neuro-Oncology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; 8. Institute of Neuropathology, University Medicine Essen, Essen, Germany; 9. Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 10. Department of Neurooncology, Centers for Neurology and Integrated Oncology (CIO), University Hospital Bonn, Bonn, Germany; 11. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; 12. Department of Neurosurgery, Universität Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 13. Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 14. Department of Neurological Surgery, Ulm University Medical Center, Ulm, Germany; 15. Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany; 16. Goethe University, Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt Am Main, Germany; 17. German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, a Partnership Between DKFZ and University Hospital Essen, Germany, DKFZ-Division Translational Neuro-Oncology at the West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 18. Medical Oncology, University Hospital Basel, Basel, Switzerland; 19. Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland; 20. Institute for Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland; 21. Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 22. Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 23. Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital of Essen, Essen, Germany; 24. Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; 25. German Cancer Consortium (DKTK), Essen, Germany; 26. Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany; 27. Institute of Pathology, Ruhr University Bochum, Bochum, Germany; 28. Department of Neurosurgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 29. Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany; 30. Institute of Neuropathology, Medical Faculty, Heinrich-Heine-University Düsseldorf, and University Hospital Düsseldorf, Düsseldorf, Germany; 31. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 32. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard-Karls-University Tübingen, Tübingen, Germany; 33. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 34. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 35. German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 36. Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany; 37. Department of Neurosurgery, Faculty of Medicine, University of Augsburg, Augsburg, Germany; 38. Department of Neurosurgery, University Hospital Münster, Münster, GermanyShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.